Medical Polybutylene Terephthalate (PBT) Market latest Statistics on Market Size, Growth, Production, Sales Volume, Sales Price, Market Share and Import vs Export 

Medical Polybutylene Terephthalate (PBT) Market Summary Highlights

The Medical Polybutylene Terephthalate (PBT) Market is gaining attention from medical device manufacturers seeking engineering thermoplastics with stable dimensional performance, electrical insulation capability, chemical resistance, and sterilization compatibility. Demand patterns in 2026 are closely linked to the expansion of minimally invasive devices, wearable diagnostics, drug delivery systems, and portable monitoring equipment. Growth remains concentrated in high-value applications rather than commodity-grade consumption, particularly in North America, Western Europe, Japan, South Korea, and selected manufacturing hubs in Southeast Asia.

Medical-grade PBT consumption is increasingly tied to the electronics intensity of healthcare equipment. Connectors, sensor housings, inhaler components, surgical instrument handles, infusion pump assemblies, and diagnostic cartridges continue to represent major application areas. The shift toward compact and lightweight medical electronics has increased preference for glass-filled and flame-retardant PBT compounds capable of maintaining structural stability under repeated sterilization cycles.

• In January 2026, Celanese expanded specialty engineered material support for healthcare customers in Asia-Pacific through additional compounding capabilities focused on medical polymers, including PBT-based formulations for diagnostic and wearable applications. Similarly, in September 2025, BASF announced additional investment in high-performance engineering plastics supply reliability for medical and electronics sectors amid rising regional demand in Asia. These developments reflect the increasing overlap between healthcare manufacturing and advanced electronics materials supply chains.

Another notable market influence emerged in March 2026 when U.S. Food and Drug Administration expanded guidance around cybersecurity and reliability standards for connected medical devices. This indirectly strengthened demand for engineering plastics with high dielectric strength and dimensional accuracy used in electronic housings and connector systems. At the same time, medical manufacturing expansion in India, Vietnam, and Mexico is increasing procurement of engineering polymers for localized device assembly.

Statistical Highlights

• The global Medical Polybutylene Terephthalate (PBT) Market is estimated at approximately USD 465 million in 2026.
• Medical electronics applications account for nearly 41% of total medical-grade PBT consumption in 2026.
• Glass-filled PBT grades represent about 46% of total market demand due to strength and dimensional stability requirements.
• North America holds an estimated 31% share of global medical PBT demand, supported by high-value medical device manufacturing.
• Asia-Pacific is projected to record the fastest demand growth, with annual consumption expansion exceeding 7.4% through 2031.
• Connector systems and sensor housings together contribute nearly 28% of total application demand in the Medical Polybutylene Terephthalate (PBT) Market.
• More than 55% of newly developed portable diagnostic devices launched during 2025–2026 incorporate engineering thermoplastics with electrical insulation capability, including PBT blends.
• Medical device outsourcing in Southeast Asia increased by approximately 11% in 2025, supporting regional demand for engineering-grade thermoplastics.
• Bio-based and recycled-content PBT compounds remain limited in medical adoption, accounting for less than 4% of total volume in 2026 due to validation and regulatory constraints.
• High-flow sterilizable grades are projected to witness above-average demand growth, particularly for disposable diagnostic cartridges and wearable monitoring systems.
• Europe accounts for nearly 24% of global consumption, supported by advanced surgical device and diagnostics manufacturing clusters in Germany, Switzerland, and Ireland.

Rising Integration of Electronics in Medical Devices

One of the strongest demand drivers for medical-grade PBT materials is the increasing electronics density in healthcare equipment. Modern medical devices contain more sensors, miniaturized connectors, embedded circuitry, and wireless communication modules than previous generations. This transition is directly increasing the need for engineering plastics capable of delivering dielectric performance alongside mechanical stability.

Medical Polybutylene Terephthalate (PBT) Market demand is especially strong in portable patient monitoring systems, insulin delivery devices, wearable cardiac monitors, imaging peripherals, and diagnostic analyzers. These applications require polymers with consistent moldability and low moisture absorption. Compared with several conventional engineering plastics, PBT offers favorable dimensional consistency under varying thermal conditions, making it suitable for precision assemblies.

In February 2026, TE Connectivity introduced additional medical interconnect solutions designed for compact diagnostic systems and wearable devices. Such launches indirectly support engineering resin demand because connector miniaturization requires materials capable of precision molding at high volumes. Medical connectors alone are projected to contribute more than USD 38 billion to the broader healthcare electronics supply chain by 2030.

Demand growth is also linked to hospital decentralization trends. Portable and home-use diagnostic systems are replacing portions of conventional centralized testing infrastructure. This transition has increased production volumes for compact polymer-intensive devices where weight reduction and design flexibility are important purchasing criteria.

Sterilization Compatibility Supporting Material Preference

Sterilization performance remains a critical selection parameter across medical materials. PBT grades used in healthcare environments are increasingly engineered to withstand ethylene oxide sterilization, gamma exposure, and selected autoclave conditions without substantial degradation in dimensional properties.

The Medical Polybutylene Terephthalate (PBT) Market benefits from this requirement because repeated sterilization cycles create stress on polymer housings and electronic components. Medical OEMs continue replacing heavier metallic assemblies with engineering polymers where feasible to reduce manufacturing complexity and overall device weight.

In 2025, several healthcare equipment manufacturers in Europe expanded production of reusable surgical platforms incorporating advanced engineering thermoplastics for handles, grips, and instrument support structures. Germany and Switzerland remain major development centers for these high-precision devices. European medical equipment exports are projected to exceed USD 340 billion in 2026, sustaining demand for high-specification polymer compounds.

At the same time, the rise in disposable medical diagnostics is creating a parallel demand stream. Single-use cartridges, testing cassettes, and diagnostic consumables require high-flow materials compatible with fast-cycle injection molding. Medical-grade PBT compounds are increasingly selected where rigidity and electrical insulation are needed simultaneously.

Expansion of Asian Medical Device Manufacturing

Asia-Pacific is emerging as the fastest-growing production center for healthcare electronics and medical assemblies. China continues to dominate large-scale electronics manufacturing, while India, Vietnam, Malaysia, and Thailand are strengthening their positions in medical device exports and contract manufacturing.

India’s medical device industry crossed USD 16 billion in estimated value during 2025, supported by production-linked incentive schemes and increased localization of diagnostic equipment manufacturing. This has strengthened procurement demand for engineering plastics, including medical PBT compounds used in molded electronic components.

The Medical Polybutylene Terephthalate (PBT) Market is also benefiting from regional supply chain diversification. Several multinational healthcare manufacturers are reducing concentration risks associated with single-country sourcing strategies. As a result, new molding and assembly operations are being established across Southeast Asia and Mexico.

In November 2025, DuPont expanded healthcare materials support programs for Asia-based device manufacturers developing miniaturized medical electronics and wearable technologies. Similar investments across the engineering plastics industry indicate that demand growth is increasingly linked to localized medical manufacturing ecosystems rather than only finished-device exports.

Higher Use of Glass-Filled and Flame-Retardant Grades

Material specifications within the Medical Polybutylene Terephthalate (PBT) Market are shifting toward reinforced formulations rather than standard unfilled grades. Glass-filled PBT compounds are increasingly preferred in applications requiring rigidity, dimensional precision, and thermal performance.

These materials are widely used in:

• Surgical navigation systems
• Imaging equipment connectors
• Electrosurgical device housings
• Battery-supported portable medical systems
• Infusion pump structural components

Flame-retardant formulations are also seeing stronger demand because healthcare electronics increasingly require compliance with stringent electrical safety standards. Hospitals are adopting larger volumes of connected equipment, including bedside monitoring systems and remote patient monitoring infrastructure, increasing the need for reliable insulating materials.

In January 2026, International Electrotechnical Commission updated selected safety-related standards affecting electrical medical equipment testing protocols. This is expected to accelerate adoption of advanced engineering plastics capable of maintaining insulation performance under stricter reliability conditions.

Sustainability Pressure Is Increasing but Adoption Remains Gradual

Sustainability targets are beginning to influence procurement discussions across healthcare plastics, although implementation remains slower than in consumer electronics or automotive sectors. Medical applications involve strict biocompatibility and validation requirements, limiting immediate substitution of established formulations.

Nevertheless, polymer producers are investing in lower-carbon engineering resin production. In April 2026, Lanxess announced expanded availability of sustainable engineering thermoplastics with reduced carbon footprint allocation models for industrial and healthcare customers. While direct medical adoption remains limited, procurement teams are increasingly evaluating lifecycle emissions alongside performance metrics.

Recyclability discussions are also gaining importance in diagnostic disposables and non-implantable device categories. However, regulatory approval cycles and sterilization validation continue to slow rapid penetration of recycled-content materials within the Medical Polybutylene Terephthalate (PBT) Market.

The market therefore remains primarily performance-driven in 2026, with sustainability acting as a secondary purchasing criterion rather than the dominant one.

Medical Polybutylene Terephthalate (PBT) Market Geographical Demand Analysis

Regional demand patterns in the Medical Polybutylene Terephthalate (PBT) Market are increasingly shaped by medical electronics manufacturing concentration, healthcare infrastructure investment, and localization of device assembly operations. Consumption growth is strongest in countries where diagnostic equipment, wearable medical systems, surgical electronics, and minimally invasive devices are expanding simultaneously.

North America continues to represent the largest high-value demand center for medical-grade PBT compounds. The United States alone accounts for a major share of global advanced medical electronics production, particularly in patient monitoring systems, diagnostic analyzers, imaging accessories, and drug delivery devices. The American Hospital Association projected healthcare capital expenditure growth above 6% for 2026, supporting procurement of technologically advanced medical systems containing high-performance engineering polymers.

Medical Polybutylene Terephthalate (PBT) Market demand in the United States is also linked to increasing deployment of connected care devices. Remote patient monitoring adoption expanded significantly between 2024 and 2026 as healthcare providers invested in decentralized care infrastructure. This trend increased procurement of sensor housings, connector assemblies, and compact electrical enclosures manufactured using reinforced PBT grades.

Canada is witnessing moderate but stable demand growth supported by diagnostic equipment manufacturing and increasing healthcare modernization expenditure. Cross-border integration with U.S. medical technology supply chains continues to support engineering thermoplastic consumption.

Europe maintains strong demand fundamentals despite relatively slower overall volume growth compared with Asia-Pacific. Germany, Switzerland, Ireland, and France remain major production hubs for surgical systems, diagnostics, and precision medical instruments. Germany’s medical technology sector surpassed EUR 45 billion in projected production value for 2026, supported by export-oriented manufacturing of high-specification healthcare equipment.

In Western Europe, the Medical Polybutylene Terephthalate (PBT) Market benefits from stringent electrical safety and sterilization requirements. Medical OEMs increasingly prefer engineering polymers capable of dimensional consistency under repeated sterilization cycles and precision molding conditions. Switzerland’s concentration of surgical device manufacturers continues to support demand for glass-filled PBT used in structural assemblies and insulated electronic components.

Asia-Pacific is registering the fastest expansion in both production and consumption. China remains the largest regional processor of engineering thermoplastics due to its dominance in electronics manufacturing infrastructure. However, demand growth is now spreading across India, Vietnam, Malaysia, Thailand, and South Korea as multinational medical device manufacturers diversify sourcing networks.

India’s medical electronics manufacturing sector is experiencing rapid expansion under domestic manufacturing incentives. Government-backed localization programs have accelerated production of diagnostic systems, portable imaging equipment, and wearable health devices. This has increased imports and domestic consumption of engineering-grade resins suitable for medical applications.

In February 2026, India Brand Equity Foundation highlighted continued expansion of India’s medical device exports, particularly in diagnostic and consumable categories. These product categories consume increasing volumes of engineering thermoplastics for molded precision components.

Japan and South Korea continue to focus on high-value applications rather than volume-based consumption. Demand in these countries is concentrated in miniaturized medical electronics, robotic surgery systems, and advanced imaging technologies. High-performance flame-retardant and low-warpage PBT grades are particularly important in these markets.

Latin America remains a smaller but steadily developing regional market. Mexico is emerging as an important assembly location for North American medical device supply chains. Several U.S.-based manufacturers expanded nearshore production capacities during 2025–2026 to reduce logistics risk and shorten delivery cycles. This has supported localized demand for engineering polymers, including medical-grade PBT compounds.

Middle East healthcare diversification projects are also contributing to incremental demand. Saudi Arabia and the United Arab Emirates continue increasing investment in domestic healthcare manufacturing and diagnostic infrastructure. While overall regional consumption remains limited compared with North America or Asia, procurement growth for imported medical assemblies is supporting downstream polymer demand.

Segmentation Highlights in the Medical Polybutylene Terephthalate (PBT) Market

By Grade Type

• Glass-filled PBT holds approximately 46% share of total market demand in 2026.
• Flame-retardant medical grades are expanding at over 7% annually due to rising electronics integration.
• Unfilled grades remain important for compact disposable components requiring precision molding.
• High-flow sterilizable formulations are witnessing stronger penetration in diagnostic consumables.

By Application

• Medical connectors and electrical components contribute nearly 28% of total consumption.
• Diagnostic equipment components account for around 22% market share.
• Drug delivery systems and wearable medical devices are among the fastest-growing application categories.
• Surgical instrument housings continue generating stable demand in developed healthcare markets.

By End Use

• Hospitals and clinical diagnostics represent the largest downstream consumption segment.
• Contract medical device manufacturing organizations are increasing procurement volumes due to outsourcing expansion.
• Home healthcare and portable monitoring systems are generating above-average growth rates.

By Region

• North America accounts for roughly 31% of global demand.
• Asia-Pacific is projected to remain the fastest-growing regional market through 2031.
• Europe maintains strong value share due to premium medical device manufacturing.
• Southeast Asia is emerging as a strategic production cluster for export-oriented healthcare electronics.

Medical Polybutylene Terephthalate (PBT) Production Trends

Global Medical Polybutylene Terephthalate (PBT) production is increasingly concentrated around integrated engineering plastics manufacturing clusters in China, Germany, the United States, Japan, and South Korea. Producers are prioritizing specialty medical-grade compounds rather than bulk commodity expansion, reflecting the technical qualification requirements of healthcare applications.

Medical Polybutylene Terephthalate (PBT) production capacity additions during 2025 and 2026 were primarily directed toward high-purity compounding, flame-retardant formulations, and glass-reinforced grades used in medical electronics. Several multinational material suppliers expanded healthcare-dedicated production lines to improve regulatory compliance and traceability standards.

China currently represents the largest overall PBT manufacturing base globally, although a substantial portion remains focused on electronics and automotive applications. Medical Polybutylene Terephthalate (PBT) production for healthcare use is growing faster in North America and Europe because medical OEMs increasingly prefer validated regional supply chains with consistent documentation and biocompatibility support.

In October 2025, Celanese increased specialty engineered material compounding capabilities for healthcare customers, including medical-grade polyester materials for electronic device applications. Similar investments by major engineering plastics suppliers indicate a strategic shift toward higher-margin healthcare compounds rather than conventional industrial resin volumes.

Medical Polybutylene Terephthalate (PBT) Market Segmentation by Application Dynamics

The application profile of the Medical Polybutylene Terephthalate (PBT) Market is becoming increasingly electronics-centric. Connector systems represent one of the strongest growth areas due to rising adoption of compact medical monitoring devices and portable diagnostics.

Healthcare providers are purchasing more digitally integrated systems capable of remote data transmission and continuous monitoring. This has increased consumption of precision-molded electrical components requiring dimensional stability and thermal resistance.

Diagnostic cartridges are another rapidly expanding segment. The shift toward decentralized testing and rapid diagnostics has accelerated production of disposable testing systems. These devices frequently require rigid polymer structures capable of maintaining tolerances in miniaturized designs.

Wearable healthcare devices are generating additional momentum. Global wearable medical device shipments are estimated to exceed 210 million units in 2026, with cardiac monitoring patches, glucose monitoring systems, and connected respiratory devices accounting for a growing portion of total demand. Engineering polymers with low moisture absorption and reliable insulation performance are increasingly preferred in these systems.

Medical Polybutylene Terephthalate (PBT) Price Trend Analysis

Medical Polybutylene Terephthalate (PBT) Price movements during 2025–2026 have remained influenced by feedstock volatility, energy costs, specialty additive pricing, and supply chain restructuring across engineering plastics markets.

Medical Polybutylene Terephthalate (PBT) Price levels increased moderately during early 2025 due to higher electricity and logistics costs affecting engineering resin production in Europe and parts of Asia. However, additional compounding capacity expansions in China and Southeast Asia helped stabilize broader supply availability entering 2026.

Medical Polybutylene Terephthalate (PBT) Price Trend patterns vary significantly by formulation type. Glass-filled and flame-retardant medical grades continue commanding premium pricing because of higher processing complexity and qualification requirements. Medical-certified compounds often trade at substantially higher levels than industrial-grade PBT due to biocompatibility testing, validation documentation, and traceability standards.

North America recorded comparatively firmer Medical Polybutylene Terephthalate (PBT) Price Trend movement in 2026 because healthcare manufacturers prioritized secure regional sourcing over low-cost imports. European prices also remained elevated due to energy-related manufacturing costs and strict compliance requirements.

Asia-Pacific continues to offer the most competitive Medical Polybutylene Terephthalate (PBT) Price environment, particularly for high-volume electronics-oriented applications. Nevertheless, premium healthcare-certified grades in Japan and South Korea continue achieving strong pricing due to technical performance advantages.

In March 2026, rising PTA and butanediol feedstock costs created temporary upward pressure on Medical Polybutylene Terephthalate (PBT) Price levels across several Asian markets. However, slower automotive sector procurement partially offset broader engineering plastics inflation, preventing sharper price escalation in healthcare applications.

Leading Manufacturers in the Medical Polybutylene Terephthalate (PBT) Market

The Medical Polybutylene Terephthalate (PBT) Market is characterized by the presence of multinational engineering plastics producers with strong healthcare material certification capabilities, global compounding infrastructure, and long-term supply agreements with medical device manufacturers. Competition remains concentrated in specialty medical-grade formulations rather than standard industrial PBT materials. Companies with expertise in sterilization-resistant compounds, flame-retardant formulations, and precision molding grades continue to hold stronger market positions.

Medical-grade PBT suppliers are increasingly focusing on healthcare electronics, wearable medical devices, minimally invasive surgical systems, and diagnostic equipment applications. The market is also witnessing higher investment in traceability systems and healthcare-focused production lines as regulatory scrutiny on medical materials continues to increase.

The top manufacturers collectively account for more than half of global Medical Polybutylene Terephthalate (PBT) Market revenue in 2026, with North America, Europe, Japan, and China remaining the primary production centers for certified healthcare compounds.

Celanese

Celanese remains one of the leading suppliers in the Medical Polybutylene Terephthalate (PBT) Market due to its broad engineering thermoplastics portfolio and established healthcare materials business. The company’s Celanex PBT product line is widely used in precision medical electronics, diagnostic devices, connector systems, and wearable healthcare equipment.

The company has strengthened its position in medical engineering plastics through expansion of healthcare-focused compounding operations and customized formulations for electrically intensive medical systems. Celanese materials are particularly preferred in applications requiring dimensional stability, low moisture absorption, and sterilization compatibility.

The company is estimated to account for approximately 16% to 18% of total global market value. Its strongest market presence is visible in North America and Asia-Pacific medical electronics manufacturing networks.

In 2026, the company expanded support for minimally invasive device manufacturers and advanced drug delivery systems, reflecting increasing demand for specialty engineering plastics in portable and connected healthcare devices.

BASF

BASF maintains a strong position through its Ultradur PBT product family, which has extensive applications across healthcare electronics and diagnostic equipment manufacturing. The company benefits from integrated engineering plastics production and a large global customer base in both medical and electronics sectors.

Ultradur medical-grade compounds are widely utilized in:

• Diagnostic analyzers
• Surgical instrument components
• Portable monitoring equipment
• Sensor housings
• Electrical connectors

BASF has particularly strong penetration in Europe and China, where demand for compact medical electronics and advanced healthcare equipment continues to increase. Flame-retardant and glass-filled PBT grades remain key growth areas for the company.

Its estimated share in the Medical Polybutylene Terephthalate (PBT) Market stands near 13% to 15%. BASF continues expanding technical support for healthcare manufacturers developing next-generation monitoring and diagnostic systems.

DuPont

DuPont continues to hold an important position in specialty medical polymers despite broader portfolio restructuring activities in recent years. The company focuses on high-performance healthcare materials designed for sterilization-intensive environments and precision medical applications.

DuPont engineering plastics are commonly used in:

• Surgical platforms
• Diagnostic cartridges
• Drug delivery systems
• Medical fluid handling equipment
• Electrical assemblies

The company’s healthcare material development strategy increasingly targets reusable medical devices requiring thermal resistance and dimensional stability during repeated sterilization cycles.

North America remains the company’s strongest regional market, although it also maintains significant relationships with European medical device manufacturers. DuPont’s share of the Medical Polybutylene Terephthalate (PBT) Market is estimated at approximately 8% to 10%.

SABIC

SABIC is steadily strengthening its healthcare engineering plastics portfolio, particularly in electrically integrated medical systems and portable healthcare devices. The company benefits from large-scale polymer manufacturing infrastructure and increasing participation in advanced healthcare materials.

Its medical-grade engineering thermoplastics are being adopted in:

• Portable diagnostic systems
• Monitoring devices
• Sterilizable housings
• Connector assemblies
• Imaging equipment components

SABIC has expanded development of specialty formulations focused on healthcare safety standards and advanced electrical insulation performance. The company’s presence is growing rapidly in Asia-Pacific and Middle Eastern healthcare manufacturing sectors.

The company currently represents an estimated 6% to 8% share of the global Medical Polybutylene Terephthalate (PBT) Market.

Lanxess

Lanxess remains an important supplier of engineering thermoplastics for healthcare and electrical applications. The company’s Pocan PBT product line is widely recognized in technical molding applications requiring mechanical strength and thermal performance.

Lanxess materials are increasingly utilized in:

• Medical electronics
• Surgical device housings
• Patient monitoring systems
• Electrical safety components

The company is also investing in lower-carbon engineering thermoplastics and sustainable production strategies, aligning with healthcare industry efforts to reduce supply chain emissions. Europe remains its strongest regional base, although demand from Asian medical manufacturing customers continues rising.

Mitsubishi Chemical Group and Toray Industries

Japanese manufacturers continue playing an important role in high-value medical engineering plastics applications. Mitsubishi Chemical Group and Toray Industries are particularly strong in miniaturized healthcare electronics, precision molding, and advanced imaging equipment.

These companies focus heavily on:

• Low-warpage formulations
• High-purity compounds
• Precision electronic applications
• Advanced dimensional stability
• Specialized medical electronics

Their overall market shares remain smaller than major global producers, but they maintain strong pricing power in technologically advanced healthcare applications where consistency and precision are critical.

Japanese suppliers continue benefiting from expansion of robotic surgery systems, compact imaging technologies, and wearable healthcare devices across East Asia.

RTP Company and Specialty Compounders

Specialty compounders are gaining importance within the Medical Polybutylene Terephthalate (PBT) Market by developing highly customized formulations for niche healthcare applications. RTP Company is among the recognized suppliers providing engineered compounds tailored to specific electrical, thermal, or sterilization requirements.

These customized compounds are increasingly used in:

• Wearable diagnostic systems
• Electrosurgical devices
• Portable patient monitoring systems
• Disposable medical electronics

Specialty compounders remain particularly competitive in projects requiring rapid formulation development and customized material performance rather than large-scale commodity supply.

Medical Polybutylene Terephthalate (PBT) Market Share by Manufacturers

The competitive structure of the Medical Polybutylene Terephthalate (PBT) Market continues shifting toward high-value specialty materials instead of volume-driven industrial grades. The leading five manufacturers collectively account for nearly 60% of global market revenue in 2026.

Key competitive factors include:

• Sterilization resistance
• Electrical insulation capability
• Biocompatibility documentation
• Multi-region production support
• Precision molding performance
• Flame-retardant technology
• Long-term supply reliability

Medical device manufacturers increasingly prefer suppliers capable of offering complete technical validation support and stable global supply chains. Once a polymer grade is validated in an approved medical device platform, material substitution becomes difficult because of additional testing and regulatory approval requirements.

This dynamic favors established multinational suppliers with strong healthcare compliance systems and global manufacturing footprints.

Recent Industry Developments

In January 2026, several healthcare polymer manufacturers expanded production support for wearable and portable medical electronics applications as demand for compact monitoring devices increased globally.

During March 2026, multiple engineering plastics suppliers introduced new sterilization-resistant and flame-retardant PBT formulations targeting minimally invasive surgical devices and connected healthcare equipment.

In late 2025, major polymer producers increased investment in Southeast Asian compounding operations to support regional medical device manufacturing growth and reduce supply chain concentration risks.

Healthcare electronics manufacturers also accelerated procurement of reinforced engineering thermoplastics during 2026 as hospitals and diagnostic centers expanded deployment of portable monitoring systems and remote patient care technologies.

Demand for high-flow medical-grade PBT compounds continued rising across diagnostic consumables and miniaturized connector systems, particularly in Asia-Pacific and North America, where healthcare electronics production remains highly active.